(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. The effect of TGFß on endoderm. Day 13 EBs were treated with various concentrations of TGFß1 for 5 days. (A) The expression of AFP was assessed by qRT-PCR and normalized to GAPDH. Results are presented relative to expression in untreated samples. (B) AFP protein expression in untreated and TGFß-treated (1 ng/ml) EBs was compared by western blotting. An anti-ß-actin antibody was used as a loading control. The expression of AFP (C,D) in control and treated samples was examined by immunofluorescence staining. DAPI-stained nuclei are also shown (E,F). Day 3 EBs were treated with various concentrations of TGFß1 for 5 days. The RNA level of (G) AFP and (H) TTR and (J) THBD was measured relative to GAPDH. Results are presented relative to expression in untreated samples. (I) Endo A protein expression in untreated and TGFß-treated (1 ng/ml) EBs was compared by western blotting.